Search results

ANSTO part of consortium funded by Federal Government to develop new radioimmunological drugs.

More than 3,200 solar panels have been installed across the rooftops of the Australian Nuclear Science and Technology Organisation’s (ANSTO) Australian Synchrotron in Clayton, offsetting enough power to light up the whole MCG for more than five years.

ANSTO expertise focused on understanding of reduced water levels at Thirlmere Lakes in three year collaborative project

A 'Challenge-Based Innovation' platform at the nandin Innovation Centre is progressing as part of a funding package from the NSW Government and a Memorandum of Understanding with Swinburne University of Technology and Design Factory Melbourne (DFM).

Lake sediments as environmental archives used in compilation of data.

ANSTO scientists were members of an inter-disciplinary team led by the University of Sydney, who examined six 19th century West African swords, using a non-invasive multi-methodological approach to reveal the composition and manufacturing history of the iron implements.

Bushfires in proximity to ANSTO during the 2018 bushfires.

Meeting of minds about potential next-generation cancer treatment for Australians

Combined users meeting highlights how ANSTO expertise and infrastructure can assist research community.

Funding awarded for research on an additive manufacturing technique for use on rail infrastructure.

Instrument scientist and expert in low dimensional magnetism Dr Kirrily Rule joins FLEET ARC Centre.

Synchrotron technique clarifies the location of calcium in a promising material with a relatively high superconducting transition temperature.

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

Australia’s new state-of-the-art nuclear medicine facility gets green light.

Paper on redefinition of the kilogram receives international award

This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.